Home › Ewing Sarcoma › Pennsylvania › Philadelphia
Ewing Sarcoma clinical trials in Philadelphia, PA
7 studies for Ewing Sarcoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
RecruitingPhase 1
- Childrens Hospital of Philadelphia, Philadelphia
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RecruitingPhase 1
- Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia
- University of Pennsylvania Abramson Cancer Center, Philadelphia
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
RecruitingPhase 1
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
Lurbinectedin in FET-Fused Tumors
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
RecruitingPhase 1/2
- Children's Hospital of Philadelphia, Philadelphia
Ewing Sarcoma trials in other cities
- New York City, NY8 studies
- Houston, TX7 studies
- Memphis, TN7 studies
- Boston, MA6 studies
- Los Angeles, CA6 studies
- Aurora, CO6 studies
- Washington, DC6 studies
- Birmingham, AL5 studies
- Atlanta, GA5 studies
- Cincinnati, OH4 studies
- Phoenix, AZ4 studies
- Columbus, OH4 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Head and Neck Squamous Cell Carcinoma26 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.